Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,392 | -3,227 | -11,428 | -8,244 | -5,257 |
| Depreciation Amortization | 435 | 197 | 791 | 594 | 398 |
| Income taxes - deferred | N/A | N/A | -531 | -349 | -226 |
| Accounts payable and accrued liabilities | 429 | 97 | -102 | 34 | -33 |
| Other Working Capital | 751 | 373 | -1,179 | -478 | -704 |
| Other Operating Activity | 2,643 | 757 | 3,730 | 2,453 | 1,384 |
| Operating Cash Flow | $-4,133 | $-1,803 | $-8,717 | $-5,990 | $-4,438 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 10,050 | 9,876 | 9,876 |
| Common Stock Repurchased | -300 | -300 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | -251 | -208 | -23 |
| Financing Cash Flow | $-300 | $-300 | $9,799 | $9,667 | $9,853 |
| Beginning Cash Position | 16,498 | 16,498 | 15,416 | 15,416 | 15,416 |
| End Cash Position | 12,064 | 14,395 | 16,498 | 19,093 | 20,831 |
| Net Cash Flow | $-4,433 | $-2,103 | $1,081 | $3,677 | $5,415 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,133 | -1,803 | -8,717 | -5,990 | -4,438 |
| Free Cash Flow | -4,133 | -1,803 | -8,717 | -5,990 | -4,438 |